Cargando...
IT-13 IPILIMUMAB FOR RECURRENT HIGH-GRADE GLIOMA: A SINGLE-INSTITUTION CASE SERIES
BACKGROUND: The anti-CTLA-4 monoclonal antibody ipilimumab is a potent immune modulator. However, experience treating high-grade glioma with ipilimumab is limited. METHODS: In this single-institution consecutive case series, we identified 7 patients with recurrent grade 3 (one patient) and grade 4 (...
Gardado en:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218229/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou258.11 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|